Found: 3
Select item for more details and to access through your institution.
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
VeriStrat<sup>®</sup> has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 11, p. 1820, doi. 10.1038/bjc.2012.470
- By:
- Publication type:
- Article